Viemed Healthcare, Inc.
VMD
$8.71
-$0.51-5.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.52% | 18.90% | 17.11% | 19.97% | 22.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.52% | 18.90% | 17.11% | 19.97% | 22.54% |
| Cost of Revenue | 26.10% | 26.05% | 24.94% | 27.36% | 29.66% |
| Gross Profit | 16.71% | 14.18% | 12.09% | 15.26% | 18.11% |
| SG&A Expenses | 15.39% | 15.71% | 14.84% | 18.56% | 20.05% |
| Depreciation & Amortization | 0.13% | -8.45% | -15.38% | -9.58% | 6.61% |
| Other Operating Expenses | 84.51% | -92.33% | -273.28% | -3,797.67% | -1,560.20% |
| Total Operating Expenses | 20.55% | 19.67% | 18.38% | 21.05% | 22.90% |
| Operating Income | 20.22% | 10.18% | 2.93% | 7.90% | 18.57% |
| Income Before Tax | 34.61% | 34.29% | 49.32% | 22.20% | 12.36% |
| Income Tax Expenses | 34.24% | 35.77% | 46.02% | 24.73% | 14.78% |
| Earnings from Continuing Operations | 34.77% | 33.66% | 50.79% | 21.17% | 11.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -206.94% | -936.11% | -3,377.78% | -- | -- |
| Net Income | 32.57% | 30.55% | 47.63% | 18.96% | 9.98% |
| EBIT | 20.22% | 10.18% | 2.93% | 7.90% | 18.57% |
| EBITDA | 15.89% | 10.06% | 5.51% | 9.08% | 17.08% |
| EPS Basic | 33.18% | 29.22% | 45.44% | 17.29% | 8.55% |
| Normalized Basic EPS | 23.98% | 12.26% | 5.35% | -6.42% | 4.04% |
| EPS Diluted | 29.57% | 31.42% | 52.92% | 22.49% | 14.58% |
| Normalized Diluted EPS | 24.42% | 11.94% | 5.02% | -6.60% | 3.87% |
| Average Basic Shares Outstanding | 0.10% | 1.10% | 1.53% | 1.41% | 1.32% |
| Average Diluted Shares Outstanding | -0.04% | 1.50% | 1.90% | 1.49% | 1.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |